 ANDOVER, Mass., Nov. 23, 2022 GLOBE NEWSWIRE -- Oncorus, Inc. Nasdaq: ONCR, a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore Ted Ashburn, M.D., Ph.D., will participate in two upcoming investor conferences: 